Article
Utility of an untargeted metabolomics approach using a 2D GC-GC‒MS platform to distinguish relapsing and progressive multiple sclerosis
2024-02-09
Abstract excerpt
<title>Abstract</title> <p>Introduction: Multiple sclerosis (MS) is the most common inflammatory neurodegenerative disease of the central nervous system (CNS) in young adults and results in progressive neurological defects. The relapsing-remitting phenotype (RRMS) is the most common disease course in MS and may progress to the progressive form (PPMS). Objectives There is a gap in knowledge regarding whether the...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Cytokine Signaling Pathways and Interactions
- Hereditary Neurological Disorders
- Long-Term Effects of COVID-19
- Metabolomics and Mass Spectrometry Studies
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Pharmacological Effects of Natural Compounds
Identifiers and source
- Literature Corpus work
- 72b7fb50-4ab5-58d6-89f0-ffea1bfec09b
- DOI
- 10.21203/rs.3.rs-3935112/v1
